Successful Treatment of Acute Prostatitis Caused by Multidrug-Resistant Escherichia coli With Tigecycline Monotherapy

Elia Lo Priore; David M Livermore; Niccolo Buetti; Philipp Jent; Niklas Pelzer; Carlo Casanova; Hansjakob Furrer; Baharak Babouee Flury

doi:10.1093/ofid/ofz551

Successful Treatment of Acute Prostatitis Caused by Multidrug-Resistant Escherichia coli With Tigecycline Monotherapy

Open Forum Infect Dis. 2020 Jan 9;7(1):ofz551. doi: 10.1093/ofid/ofz551. eCollection 2020 Jan.

Authors

Elia Lo Priore¹, David M Livermore², Niccolo Buetti¹, Philipp Jent¹, Niklas Pelzer³, Carlo Casanova⁴, Hansjakob Furrer¹, Baharak Babouee Flury^{1

4}

Affiliations

¹ Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
² Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
³ UroSwiss AG, Department of Urology, Oberaargau Regional Hospital, Langenthal, Switzerland.
⁴ Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Abstract

We present a successful treatment, with tigecycline monotherapy, of acute prostatitis caused by multidrug-resistant Escherichia coli harboring an NDM-1 carbapemenase along with a CMY-2 cephalosporinase and a TEM ESBL.

Keywords: CMY-2; NDM-1; TEM ESBL; prostatitis; tigecyclin.

Publication types

Case Reports